95 related articles for article (PubMed ID: 22137623)
1. [Infliximab].
Goujon C; Bachelez H
Ann Dermatol Venereol; 2011 Dec; 138(12):839-41. PubMed ID: 22137623
[No Abstract] [Full Text] [Related]
2. [Patient education. Information letter on treatment of psoriasis with infliximab (Remicade)].
Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011
Ann Dermatol Venereol; 2011 Dec; 138(12):865-7. PubMed ID: 22137633
[No Abstract] [Full Text] [Related]
3. [Ustekinumab].
Ortonne JP
Ann Dermatol Venereol; 2011 Dec; 138(12):848-50. PubMed ID: 22137626
[No Abstract] [Full Text] [Related]
4. [Patient education. Information letter on treatment of psoriasis with ustekinumab (Stelara)].
Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011
Ann Dermatol Venereol; 2011 Dec; 138(12):874-5. PubMed ID: 22137636
[No Abstract] [Full Text] [Related]
5. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate.
Warren RB; Brown BC; Carmichael AJ; Griffiths CE
Clin Exp Dermatol; 2009 Apr; 34(3):415-6. PubMed ID: 19120390
[No Abstract] [Full Text] [Related]
6. Infliximab for the treatment of extensive plaque psoriasis--regulation, cost and reimbursement.
Rabinovich M; Fainaru M
Isr Med Assoc J; 2003 Nov; 5(11):817-8. PubMed ID: 14650110
[No Abstract] [Full Text] [Related]
7. [Our experience with infliximab in reclacitrant cases of psoriasis].
Pereiro M; González-Vilas D; Sánchez-Aguilar D; Toribio J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():43-7. PubMed ID: 19080991
[TBL] [Abstract][Full Text] [Related]
8. Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis.
Takahashi MD; Castro LG; Romiti R
Br J Dermatol; 2007 Oct; 157(4):828-31. PubMed ID: 17711530
[No Abstract] [Full Text] [Related]
9. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
Heikkilä H; Ranki A; Cajanus S; Karvonen SL
Arch Dermatol; 2005 Dec; 141(12):1607-10. PubMed ID: 16365275
[No Abstract] [Full Text] [Related]
10. Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasis.
Lisby S; Gniadecki R
Acta Derm Venereol; 2004; 84(3):247-8. PubMed ID: 15202853
[No Abstract] [Full Text] [Related]
11. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
[TBL] [Abstract][Full Text] [Related]
12. Ustekinumab (Stelara) for psoriasis.
Med Lett Drugs Ther; 2010 Jan; 52(1330):7-8. PubMed ID: 20208473
[No Abstract] [Full Text] [Related]
13. Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab.
Bartke U; Venten I; Kreuter A; Gubbay S; Altmeyer P; Brockmeyer NH
Br J Dermatol; 2004 Apr; 150(4):784-6. PubMed ID: 15099388
[No Abstract] [Full Text] [Related]
14. [Personal experience with the use of infliximab].
Carretero G
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():36-42. PubMed ID: 19080990
[TBL] [Abstract][Full Text] [Related]
15. New development in the treatment of psoriasis--infliximab.
Pietrzak A; Chodorowska G; Jazienicka I; Junak-Bojarska A; Roliński J
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):322-7. PubMed ID: 15315008
[TBL] [Abstract][Full Text] [Related]
16. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
Lewis TG; Tuchinda C; Lim HW; Wong HK
J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
[TBL] [Abstract][Full Text] [Related]
17. Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab.
Böhner A; Roenneberg S; Eyerich K; Eberlein B; Biedermann T
JAMA Dermatol; 2016 Apr; 152(4):482-4. PubMed ID: 26650014
[No Abstract] [Full Text] [Related]
18. [Up-date on the use of infliximab in dermatology. Introduction].
Sánchez-Carazo J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
[No Abstract] [Full Text] [Related]
19. Serum sickness due to infliximab in a patient with psoriasis.
Krishnan RS; Hsu S
J Drugs Dermatol; 2004; 3(3):305-8. PubMed ID: 15176166
[TBL] [Abstract][Full Text] [Related]
20. Infliximab- and methotrexate-resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva).
Thielen AM; Barde C; Saurat JH
Br J Dermatol; 2006 Oct; 155(4):846-7. PubMed ID: 16965444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
